−0.015AUD
−3.79 MAUD
1.80 MAUD
190.66 M
About IMMURON LIMITED
Sector
CEO
Steven Lydeamore
Headquarters
Carlton
Website
Founded
1994
ISIN
AU000000IMC7
FIGI
BBG000C6G8P0
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce at mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IMC is 0.100 AUD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange IMMURON LIMITED stocks are traded under the ticker IMC.
IMMURON LIMITED is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
IMC stock is 2.00% volatile and has beta coefficient of 2.56. Check out the list of the most volatile stocks — is IMMURON LIMITED there?
Yes, you can track IMMURON LIMITED financials in yearly and quarterly reports right on TradingView.
IMC stock has fallen by 13.04% compared to the previous week, the last month showed zero change in price, over the last year IMMURON LIMITED has showed a 29.87% increase.
IMC net income for the last quarter is −2.07 M AUD, while the quarter before that showed −1.81 M AUD of net income which accounts for −14.66% change. Track more IMMURON LIMITED financial stats to get the full picture.
Today IMMURON LIMITED has the market capitalization of 22.80 M, it has decreased by 15.38% over the last week.
No, IMC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, IMC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMURON LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMURON LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMURON LIMITED stock shows the neutral signal. See more of IMMURON LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.